{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:46:52Z","timestamp":1791838012747,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["H30MC24049"],"award-info":[{"award-number":["H30MC24049"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151984"],"award-info":[{"award-number":["R01HL151984"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/18\/3\/33405"],"award-info":[{"award-number":["RG\/18\/3\/33405"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/20\/13\/34994"],"award-info":[{"award-number":["PG\/20\/13\/34994"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Journal"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bpj.2026.03.014","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:48:01Z","timestamp":1773272881000},"page":"1820-1839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanisms of thrombin inhibition by protein S and the TFPI\u03b1-fVshort-protein S complex"],"prefix":"10.1016","volume":"125","author":[{"given":"Alexander G.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Ahnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.B.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leiderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dougald M.","family":"Monroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith B.","family":"Neeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne F.","family":"Sindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-9420","authenticated-orcid":false,"given":"Aaron L.","family":"Fogelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpj.2026.03.014_bib1","series-title":"Guyton and Hall Textbook of Medical Physiology","author":"Guyton","year":"2011"},{"key":"10.1016\/j.bpj.2026.03.014_bib2","series-title":"Platelets","first-page":"371","article-title":"Hemostatic thrombus formation in flowing blood","author":"Brass","year":"2019"},{"key":"10.1016\/j.bpj.2026.03.014_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112772","article-title":"Platelets and their role in hemostasis and thrombosis\u2014From physiology to pathophysiology and therapeutic implications","volume":"23","author":"Scridon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bpj.2026.03.014_bib4","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","article-title":"The growing complexity of platelet aggregation","volume":"109","author":"Jackson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib5","series-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","author":"Marder","year":"2012"},{"key":"10.1016\/j.bpj.2026.03.014_bib6","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15025","article-title":"Anticoagulant protein S\u2014New insights on interactions and functions","volume":"18","author":"Gierula","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib7","first-page":"785","article-title":"Thrombosis and platelets: an update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bpj.2026.03.014_bib8","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.3390\/ijms21217975","article-title":"Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds","volume":"21","author":"Lichota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bpj.2026.03.014_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jtha.2023.01.033","article-title":"Natural anticoagulant discovery, the gift that keeps on giving: finding fV-Short","volume":"21","author":"Dahlb\u00e4ck","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jtha.2025.10.024","article-title":"Protein S as a therapeutic target","volume":"24","author":"Eladnani","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bpj.2026.03.014_bib11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood-2017-09-800326","article-title":"Targeting anticoagulant protein S to improve hemostasis in hemophilia","volume":"131","author":"Prince","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jtha.2025.03.021","article-title":"Enhancing hemostasis potency in hemophilia with a small interfering RNA targeting protein S","volume":"23","author":"Eladnani","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bpj.2026.03.014_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/bloodadvances.2023010819","article-title":"Protein S antibody as an adjunct therapy for hemophilia B","volume":"8","author":"Wilson","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.bpj.2026.03.014_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/bi00623a022","article-title":"A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S","volume":"16","author":"Di Scipio","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpj.2026.03.014_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3324\/haematol.12691","article-title":"Protein S deficiency","volume":"93","author":"D\u2019Angelo","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bpj.2026.03.014_bib16","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.bpj.2026.03.014_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOH.0000000000000838","article-title":"Tissue factor pathway inhibitor\u2013cofactor-dependent regulation of the initiation of coagulation","volume":"31","author":"Ahnstr\u00f6m","year":"2024","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bpj.2026.03.014_bib18","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2014-01-551812","article-title":"TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain","volume":"123","author":"Regli\u0144ska-Matveyev","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102570","article-title":"Mathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII-IX-or XI-deficient blood","volume":"8","author":"Stobb","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bpj.2026.03.014_bib21","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1182\/blood-2012-05-432005","article-title":"Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S","volume":"120","author":"Ahnstr\u00f6m","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib22","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2009-10-246686","article-title":"The Kunitz-3 domain of TFPI-\u03b1 is required for protein S\u2013dependent enhancement of factor Xa inhibition","volume":"116","author":"Ndonwi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib23","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.jtha.2023.09.003","article-title":"The TFPI\u03b1 C-terminal tail is essential for TFPI\u03b1-fV-short-protein S complex formation and synergistic enhancement of TFPI\u03b1","volume":"21","author":"Gierula","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/ATVBAHA.113.302655","article-title":"Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-\u03b1 but not for cell surface\u2013associated tissue factor pathway inhibitor","volume":"34","author":"Wood","year":"2014","journal-title":"Arterio Thromb Vas Bio"},{"key":"10.1016\/j.bpj.2026.03.014_bib25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/jth.13665","article-title":"Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitor\u03b1, and protein S","volume":"15","author":"Dahlb\u00e4ck","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/46594","article-title":"Crystal structures of the membrane-binding C2 domain of human coagulation factor V","volume":"402","author":"Macedo-Ribeiro","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bpj.2026.03.014_bib27","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V A2440G causes east Texas bleeding disorder via TFPI\u03b1","volume":"123","author":"Vincent","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bpj.2026.03.014_bib28","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.bpj.2026.03.014_bib29","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016341","article-title":"Regulation of factor V and factor V-short by TFPI\u03b1: relationship between B-domain proteolysis and binding","volume":"296","author":"Petrillo","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpj.2026.03.014_bib30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.15690","article-title":"A hydrophobic patch (PLVIVG; 1481\u20131486) in the B-domain of factor V-short is crucial for its synergistic TFPI\u03b1-cofactor activity with protein S and for the formation of the fXa-inhibitory complex comprising FV-short, TFPI\u03b1, and protein S","volume":"20","author":"Dahlb\u00e4ck","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/rth2.12057","article-title":"factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPI\u03b1) cofactors","volume":"2","author":"Dahlb\u00e4ck","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V97.6.1549","article-title":"Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas","volume":"97","author":"Kuang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib33","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0006-3495(01)76085-7","article-title":"Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition","volume":"80","author":"Kuharsky","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.bpj.2026.03.014_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000089930","article-title":"Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation","volume":"34","author":"Fogelson","year":"2005","journal-title":"Pathophysiol Haemo Thromb"},{"key":"10.1016\/j.bpj.2026.03.014_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bpj.2011.10.048","article-title":"Blood clot formation under flow: the importance of factor XI depends strongly on platelet count","volume":"102","author":"Fogelson","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.bpj.2026.03.014_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jth.14653","article-title":"A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A","volume":"18","author":"Link","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bpj.2022.11.023","article-title":"Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI","volume":"122","author":"Miyazawa","year":"2023","journal-title":"Biophys. J."},{"key":"10.1016\/j.bpj.2026.03.014_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bpj.2022.10.038","article-title":"Inhibition of platelet-surface-bound proteins during coagulation under flow II: Antithrombin and heparin","volume":"122","author":"Miyazawa","year":"2023","journal-title":"Biophys. J."},{"key":"10.1016\/j.bpj.2026.03.014_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200917","article-title":"A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow","volume":"13","author":"Link","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bpj.2026.03.014_bib42","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.V66.6.1452.1452","article-title":"Identification and quantitation of protein S in human platelets","volume":"66","author":"Schwarz","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib43","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2006-07-037283","article-title":"Active tissue factor pathway inhibitor is expressed on the surface of coated platelets","volume":"109","author":"Maroney","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH12-08-0622","article-title":"Platelet protein S directly inhibits procoagulant activity on platelets and microparticles","volume":"109","author":"Stavenuiter","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1172\/JCI112822","article-title":"Cleavage of protein S by a platelet membrane protease","volume":"79","author":"Mitchell","year":"1987","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bpj.2026.03.014_bib46","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","article-title":"The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways","volume":"120","author":"Burkhart","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bpj.2026.03.014_bib47","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1074\/jbc.M116.769570","article-title":"Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation","volume":"292","author":"Santamaria","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpj.2026.03.014_bib48","doi-asserted-by":"crossref","first-page":"26950","DOI":"10.1016\/S0021-9258(19)74202-1","article-title":"Kinetics of factor Xa inhibition by tissue factor pathway inhibitor","volume":"268","author":"Huang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpj.2026.03.014_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0037-1614633","article-title":"Regulation of prothrombinase activity by protein S","volume":"82","author":"van\u2019t Veer","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1538-7836.2008.02980.x","article-title":"Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa\u2013tissue factor","volume":"6","author":"Ndonwi","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib50","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1073\/pnas.91.7.2728","article-title":"Protein S binds to and inhibits factor Xa","volume":"91","author":"Heeb","year":"1994","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.bpj.2026.03.014_bib52","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3324\/haematol.2020.253047","article-title":"Thrombin generation: a global coagulation procedure to investigate hypo-and hyper-coagulability","volume":"105","author":"Tripodi","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bpj.2026.03.014_bib53","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","article-title":"Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine","volume":"19","author":"Depasse","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2005.05612.x","article-title":"The measurement and application of thrombin generation","volume":"130","author":"Baglin","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bpj.2026.03.014_bib55","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(11)70007-X","article-title":"Thrombin generation tests","volume":"127","author":"Castoldi","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bpj.2026.03.014_bib56","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1074\/jbc.273.8.4378","article-title":"Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor","volume":"273","author":"Baugh","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpj.2026.03.014_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12679","article-title":"Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model","volume":"6","author":"Pittman","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.bpj.2026.03.014_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.thromres.2013.12.015","article-title":"Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz\u2013type protease inhibitor 2 domain of tissue factor pathway inhibitor","volume":"133","author":"Hansen","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bpj.2026.03.014_bib59","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1182\/blood-2012-01-401620","article-title":"Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model","volume":"119","author":"Hilden","year":"2012","journal-title":"Blood"}],"container-title":["Biophysical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006349526001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006349526001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:06:44Z","timestamp":1791835604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006349526001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0006349526001864"],"URL":"https:\/\/doi.org\/10.1016\/j.bpj.2026.03.014","relation":{},"ISSN":["0006-3495"],"issn-type":[{"value":"0006-3495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of thrombin inhibition by protein S and the TFPI\u03b1-fVshort-protein S complex","name":"articletitle","label":"Article Title"},{"value":"Biophysical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpj.2026.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Biophysical Society.","name":"copyright","label":"Copyright"}]}}